Suppr超能文献

单纯型和复杂型慢性淋巴细胞白血病的腺脾肿大与预后:362例研究

Adenosplenomegaly and prognosis in uncomplicated and complicated chronic lymphocytic leukemia. A study of 362 cases.

作者信息

Paolino W, Infelise V, Levis A, Marmont F, Vitolo U, Paolino F, Rossi M, Jayme A, Remondino M

出版信息

Cancer. 1984 Jul 15;54(2):339-46. doi: 10.1002/1097-0142(19840715)54:2<339::aid-cncr2820540227>3.0.co;2-h.

Abstract

Presence and size of lymph nodes and spleen, graded from 0 to , in 362 patients with CLL observed from diagnosis were evaluated. Statistical analysis showed a relationship with age, sex, anemia and thrombopenia, leukocytosis, and outlined two different groups: the one without organomegalies , with higher mean age (67 years), female prevalence, and better prognosis; the other with adenosplenomegaly graded ++/ , with lower mean age (57 years), clear male prevalence, and worse prognosis. Survival results were statistically different only between groups 0/+ versus group ++/ . Important chronic diseases were present at diagnosis in approximately 25% of the cases, with a severely reduced survival (median, 27 months), close to that of the cases with anemia and/or thrombopenia (22 months). Therefore it seems that in every prognostic grouping system, complicated cases should be taken into account and grouped with the anemic and/or the thrombopenic ones. The following prognostic groups are proposed: I: low risk: cases without or with adenomegaly and/or splenomegaly + (65% surviving at 100 months); II: intermediate risk: cases with adenomegaly and/or splenomegaly ++/ (median survival, 70 months); III: high risk: cases complicated by chronic diseases, or with anemia and/or thrombopenia (median survival, 25 months).

摘要

对362例慢性淋巴细胞白血病(CLL)患者自诊断起观察其淋巴结和脾脏的存在情况及大小,并按0至 进行分级评估。统计分析显示其与年龄、性别、贫血和血小板减少症、白细胞增多相关,并勾勒出两个不同的组:一组无脏器肿大,平均年龄较高(67岁),女性患病率高,预后较好;另一组有++/ 级的脾肿大,平均年龄较低(57岁),男性患病率明显,预后较差。生存结果仅在0/+组与++/ 组之间存在统计学差异。约25%的病例在诊断时存在重要的慢性疾病,其生存率严重降低(中位数为27个月),与贫血和/或血小板减少症患者的情况相近(22个月)。因此,似乎在每个预后分组系统中,都应考虑复杂病例并将其与贫血和/或血小板减少症患者归为一组。现提出以下预后分组:I:低风险:无或有淋巴结肿大和/或脾肿大 + 的病例(100个月时65%存活);II:中风险:有淋巴结肿大和/或脾肿大 ++/ 的病例(中位生存期70个月);III:高风险:合并慢性疾病或有贫血和/或血小板减少症的病例(中位生存期25个月)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验